rank	phenotype	cui	assoc in neigh	assoc in intom	probability	Benjamini-Hochberg	genes	
1	Astrocytoma	C0004114	1	674	0.0	5.8479532163742686e-06	BCL2L1
2	Malignant Glioma	C0555198	1	412	0.0	1.1695906432748537e-05	BCL2L1
3	Neurodegenerative Diseases	C0524851	1	706	0.0	1.7543859649122806e-05	BCL2L1
4	Hyperoxia	C0242706	1	45	0.0	2.3391812865497074e-05	BCL2L1
5	Heart Diseases	C0018799	1	386	0.0	2.9239766081871343e-05	BCL2L1
7	Myocardial Infarction	C0027051	1	1019	0.0	4.093567251461988e-05	BCL2L1
8	Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	C0334634	1	327	0.0	4.678362573099415e-05	BCL2L1
9	Small cell lung cancer	C0149925	1	638	0.0	5.263157894736842e-05	BCL2L1
10	Liver regeneration disorder	C1318485	1	87	0.0	5.8479532163742686e-05	BCL2L1
11	Hypoxia	C0003130	1	335	0.0	6.432748538011695e-05	BCL2L1
13	Glioblastoma	C0017636	1	1645	0.0	7.602339181286549e-05	BCL2L1
14	Intestinal Cancer	C0346627	1	40	0.0	8.187134502923976e-05	BCL2L1
15	Rash and Dermatitis Adverse Event Associated with Chemoradiation	C1559154	1	80	0.0	8.771929824561403e-05	BCL2L1
16	Symptomatic human immunodeficiency virus infection	C0019693	1	1900	0.0	9.35672514619883e-05	BCL2L1
17	Ovarian Neoplasms	C0919267	1	942	0.0	9.941520467836257e-05	BCL2L1
18	Anaplastic large cell lymphoma, ALK negative	C0206180	1	263	0.0	0.00010526315789473683	BCL2L1
19	Rectal Carcinoma	C0149978	1	286	0.0	0.0001111111111111111	BCL2L1
20	Thyroiditis	C0040147	1	134	0.0	0.00011695906432748537	BCL2L1
21	Diabetes mellitus type 1	C0011854	1	1104	0.0	0.00012280701754385965	BCL2L1
22	Diabetes mellitus type 2	C0011860	1	1972	0.0	0.0001286549707602339	BCL2L1
23	granulosa cell tumor	C0018206	1	83	0.0	0.0001345029239766082	BCL2L1
24	Monoclonal Gammopathy of Undetermined Significance	C0026470	1	144	0.0	0.00014035087719298245	BCL2L1
25	Malignant tumor of esophagus	C0546837	1	650	0.0	0.00014619883040935673	BCL2L1
26	Adult Acute Myeloblastic Leukemia	C0220615	1	90	0.0	0.00015204678362573098	BCL2L1
27	Ocular Hypertension	C0028840	1	44	0.0	0.00015789473684210527	BCL2L1
28	Impotence	C0242350	1	126	0.0	0.00016374269005847952	BCL2L1
29	Glioma	C0017638	1	1997	0.0	0.0001695906432748538	BCL2L1
30	Ischemia	C0022116	1	647	0.0	0.00017543859649122806	BCL2L1
31	Squamous cell carcinoma of the head and neck	C1168401	1	825	0.0	0.00018128654970760234	BCL2L1
32	Hearing impairment	C1384666	1	1031	0.0	0.0001871345029239766	BCL2L1
33	Fibrosarcoma	C0016057	1	254	0.0	0.00019298245614035088	BCL2L1
34	Leukemia, Lymphocytic, Acute, L1	C0023452	1	388	0.0	0.00019883040935672513	BCL2L1
35	Discoid lupus erythematosus	C0024138	1	319	0.0	0.00020467836257309941	BCL2L1
36	Mammary Neoplasms, Experimental	C0024668	1	207	0.0	0.00021052631578947367	BCL2L1
37	Lymphoproliferative disorder	C0024314	1	236	0.0	0.00021637426900584795	BCL2L1
39	Oropharyngeal squamous cell carcinoma	C0280313	1	58	0.0	0.0002280701754385965	BCL2L1
40	Esophageal carcinoma	C0152018	1	585	0.0	0.00023391812865497074	BCL2L1
41	Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma	C0079744	1	568	0.0	0.00023976608187134503	BCL2L1
42	Hypoxia-Ischemia, Brain	C0752308	1	66	0.0	0.0002456140350877193	BCL2L1
43	Plasmacytoma	C0032131	1	89	0.0	0.00025146198830409354	BCL2L1
44	T-cell acute lymphoblastic leukemias	C1961099	1	371	0.0	0.0002573099415204678	BCL2L1
45	Acute kidney injury	C0022660	1	270	0.0	0.0002631578947368421	BCL2L1
46	Malignant gastrointestinal tract tumors	C0685938	1	251	0.0	0.0002690058479532164	BCL2L1
47	Urothelial Carcinoma	C0007138	1	391	0.0	0.0002748538011695906	BCL2L1
48	Colon cancer	C0007102	1	1727	0.0	0.0002807017543859649	BCL2L1
49	Non-small cell lung carcinoma	C0007131	1	1993	0.0	0.0002865497076023392	BCL2L1
50	Lymphoma, Large B-Cell, Diffuse	C0024299	1	1362	0.0	0.00029239766081871346	BCL2L1
51	Breast-ovarian cancer, familial 1	C0006142	1	4543	0.0	0.0002982456140350877	BCL2L1
52	Carcinogenesis	C0596263	1	3723	0.0	0.00030409356725146197	BCL2L1
53	 Adenocarcinoma, ovarian, somatic, 167000 (3)	C0001418	1	1700	0.0	0.00030994152046783625	BCL2L1
54	Immunodeficiency due to defect in CD3-gamma	C0021051	1	571	0.0	0.00031578947368421053	BCL2L1
55	Tumor Progression	C0178874	1	1969	0.0	0.00032163742690058476	BCL2L1
56	Memory Loss	C0002622	1	61	0.0	0.00032748538011695904	BCL2L1
57	Lupus Vulgaris	C0024131	1	307	0.0	0.0003333333333333333	BCL2L1
58	Adenomatous Polyps	C0206677	1	72	0.0	0.0003391812865497076	BCL2L1
59	Pancreatic Carcinoma	C0235974	1	1690	0.0	0.0003450292397660819	BCL2L1
60	Malignant neoplasm of pancreas	C0346647	1	1625	0.0	0.0003508771929824561	BCL2L1
61	Acute myeloid leukemia	C0023467	1	1733	0.0	0.0003567251461988304	BCL2L1
62	Amyotrophic Lateral Sclerosis	C0002736	1	812	0.0	0.0003625730994152047	BCL2L1
63	Neoplasm of the liver	C0023903	1	1290	0.0	0.00036842105263157896	BCL2L1
64	Asthma	C0004096	1	1454	0.0	0.0003742690058479532	BCL2L1
65	Skin Carcinogenesis	C1519346	1	110	0.0	0.00038011695906432747	BCL2L1
66	Brain Ischemia	C0007786	1	415	0.0	0.00038596491228070175	BCL2L1
67	Malignant neoplasm of lung	C0242379	1	2460	0.0	0.00039181286549707604	BCL2L1
68	Neurotoxicity Syndromes	C0235032	1	40	0.0	0.00039766081871345026	BCL2L1
69	Osteosarcoma	C0585442	1	936	0.0	0.00040350877192982455	BCL2L1
70	B-cell lymphoma	C0079731	1	652	0.0	0.00040935672514619883	BCL2L1
71	Adenomas, multiple colorectal, 608456 (3)	C0001430	1	975	0.0	0.0004152046783625731	BCL2L1
72	Liver Neoplasms, Experimental	C0023904	1	136	0.0	0.00042105263157894734	BCL2L1
73	Arthritis, Rheumatoid	C0003864	1	1030	0.0	0.0004269005847953216	BCL2L1
74	Cholangiocarcinoma	C0206698	1	401	0.0	0.0004327485380116959	BCL2L1
75	Leukemogenesis	C0598766	1	660	0.0	0.0004385964912280702	BCL2L1
76	Secondary hypertriglyceridemia	C0027627	1	3444	0.0	0.0004444444444444444	BCL2L1
77	Pheochromocytoma	C0031511	1	259	0.0	0.0004502923976608187	BCL2L1
78	Mastocytosis	C0024899	1	57	0.0	0.000456140350877193	BCL2L1
79	Chronic myeloid leukemia	C0023473	1	822	0.0	0.00046198830409356726	BCL2L1
80	Polycythemia	C0032461	1	81	0.0	0.0004678362573099415	BCL2L1
81	Severe Acute Respiratory Syndrome	C1175175	1	99	0.0	0.00047368421052631577	BCL2L1
82	Polycythemia vera	C0032463	1	192	0.0	0.00047953216374269005	BCL2L1
83	Carcinoma, Pancreatic Ductal	C0887833	1	65	0.0	0.00048538011695906433	BCL2L1
84	Renal cell carcinoma, nonpapillary	C0007134	1	1418	0.0	0.0004912280701754386	BCL2L1
85	gastritis h pylori	C0744310	1	29	0.0	0.0004970760233918128	BCL2L1
86	Follicular neoplasm	C0474808	1	33	0.0	0.0005029239766081871	BCL2L1
87	Lymphopenia	C0024312	1	122	0.0	0.0005087719298245614	BCL2L1
88	Amyotrophic lateral sclerosis type 1	C1862939	1	171	0.0	0.0005146198830409356	BCL2L1
89	Neoplasm of the thymus	C3714644	1	31	0.0	0.00052046783625731	BCL2L1
90	Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation	C0751690	1	151	0.0	0.0005263157894736842	BCL2L1
92	Combined Hepatocellular Carcinoma and Cholangiocarcinoma	C0221287	1	497	0.0	0.0005380116959064328	BCL2L1
93	Melanoma	C0025202	1	2386	0.0	0.0005438596491228071	BCL2L1
94	Parkinson Disease	C0030567	1	789	0.0	0.0005497076023391812	BCL2L1
95	Colorectal cancer	C1527249	1	2681	0.0	0.0005555555555555556	BCL2L1
96	Bladder carcinoma	C0699885	1	1087	0.0	0.0005614035087719298	BCL2L1
97	Malformation of cortical development	C1955869	1	68	0.0	0.0005672514619883041	BCL2L1
98	Seizures, Febrile	C0036572	1	1535	0.0	0.0005730994152046783	BCL2L1
99	Head and Neck Neoplasms	C0018671	1	333	0.0	0.0005789473684210527	BCL2L1
100	Blast Phase	C0005699	1	221	0.0	0.0005847953216374269	BCL2L1
101	Cancer Cell Growth	C1516170	1	320	0.0	0.0005906432748538012	BCL2L1
102	Malignant tumor of prostate	C0376358	1	2940	0.0	0.0005964912280701754	BCL2L1
103	Hyperglycemia	C0020456	1	459	0.0	0.0006023391812865497	BCL2L1
104	Metastatic melanoma	C0278883	1	333	0.0	0.0006081871345029239	BCL2L1
105	Non-Malignant Ascites Adverse Event	C1559271	1	181	0.0	0.0006140350877192983	BCL2L1
106	Shock, Septic	C0036974	1	69	0.0	0.0006198830409356725	BCL2L1
107	Cryptorchidism	C0010417	1	630	0.0	0.0006257309941520468	BCL2L1
108	Prostatic Neoplasms	C0033578	1	1606	0.0	0.0006315789473684211	BCL2L1
109	Prostate carcinoma	C0600139	1	2734	0.0	0.0006374269005847954	BCL2L1
110	Pancreatic Neoplasms	C0030297	1	750	0.0	0.0006432748538011695	BCL2L1
111	Esophageal Neoplasms	C0014859	1	686	0.0	0.0006491228070175439	BCL2L1
112	Depressive Disorder	C0011581	1	543	0.0	0.0006549707602339181	BCL2L1
113	Neoplasm of the colon	C0009375	1	817	0.0	0.0006608187134502924	BCL2L1
114	Pleural Mesothelioma	C0812413	1	240	0.0	0.0006666666666666666	BCL2L1
115	Liver Diseases	C0023895	1	586	0.0	0.000672514619883041	BCL2L1
116	Esophageal Squamous Cell Carcinoma	C0279626	1	888	0.0	0.0006783625730994152	BCL2L1
117	Stomach cancer	C0699791	1	2109	0.0	0.0006842105263157895	BCL2L1
118	Malignant tumor of urinary bladder	C0005684	1	1371	0.0	0.0006900584795321638	BCL2L1
119	Mesothelioma, malignant	C0025500	1	383	0.0	0.000695906432748538	BCL2L1
120	Essential thrombocythemia	C0040028	1	150	0.0	0.0007017543859649122	BCL2L1
121	Spinal muscular atrophy with congenital bone fractures 2	C0026847	1	187	0.0	0.0007076023391812866	BCL2L1
122	Hepatoblastoma	C0206624	1	220	0.0	0.0007134502923976608	BCL2L1
123	Adenoma of large intestine	C1302401	1	257	0.0	0.0007192982456140351	BCL2L1
124	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	C1140680	1	1967	0.0	0.0007251461988304094	BCL2L1
125	Diabetes Mellitus, Type 1	C0011849	1	2081	0.0	0.0007309941520467837	BCL2L1
126	Hepatocellular carcinoma	C2239176	1	3108	0.0	0.0007368421052631579	BCL2L1
127	Non-Hodgkin lymphoma	C0024305	1	556	0.0	0.0007426900584795321	BCL2L1
128	{Systemic lupus erythematosus, susceptibility to, 8} (2)	C0409974	1	393	0.0	0.0007485380116959064	BCL2L1
129	DiGeorge sequence	C0012236	1	87	0.0	0.0007543859649122807	BCL2L1
130	Rheumatoid arthritis	C0003873	1	1856	0.0	0.0007602339181286549	BCL2L1
131	Osteoarthritis	C0029408	1	942	0.0	0.0007660818713450293	BCL2L1
132	Glaucoma, Angle-Closure	C0017601	1	461	0.0	0.0007719298245614035	BCL2L1
133	Solid tumour	C0280100	1	772	0.0	0.0007777777777777778	BCL2L1
134	Breast carcinoma	C0678222	1	4281	0.0	0.0007836257309941521	BCL2L1
135	Death, Sudden, Cardiac	C0011065	1	203	0.0	0.0007894736842105263	BCL2L1
136	Cerebral Hemorrhage	C2937358	1	246	0.0	0.0007953216374269005	BCL2L1
137	Hepatitis C	C0019196	1	721	0.0	0.0008011695906432749	BCL2L1
138	Chronic Lymphocytic Leukemia	C0023434	1	1176	0.0	0.0008070175438596491	BCL2L1
139	Cancer of mouth	C0153381	1	420	0.0	0.0008128654970760234	BCL2L1
140	Lupus Erythematosus, Systemic	C0024141	1	1467	0.0	0.0008187134502923977	BCL2L1
141	Myeloid leukemia	C0023470	1	533	0.0	0.000824561403508772	BCL2L1
142	Endothelial dysfunction	C0856169	1	216	0.0	0.0008304093567251462	BCL2L1
143	Renal neoplasm	C0022665	1	363	0.0	0.0008362573099415204	BCL2L1
144	Leukemia, Lymphocytic, Chronic, B-Cell	C0023418	1	1913	0.0	0.0008421052631578947	BCL2L1
145	Lip and Oral Cavity Carcinoma	C0220641	1	419	0.0	0.000847953216374269	BCL2L1
146	Alzheimer Disease	C0002395	1	1699	0.0	0.0008538011695906432	BCL2L1
147	Lymphoma, Follicular	C0024301	1	389	0.0	0.0008596491228070176	BCL2L1
148	Tumor Initiation	C0598935	1	182	0.0	0.0008654970760233918	BCL2L1
149	Lung Neoplasms	C0024121	1	1155	0.0	0.0008713450292397661	BCL2L1
150	Lewy Body Disease	C0752347	1	132	0.0	0.0008771929824561404	BCL2L1
151	Secondary malignant neoplasm of pancreas	C3266877	1	1540	0.0	0.0008830409356725146	BCL2L1
152	Colorectal cancer 1	C0009402	1	2543	0.0	0.0008888888888888888	BCL2L1
153	{Gastric cancer risk after H. pylori infection}, 137215 (3)	C0024623	1	2073	0.0	0.0008947368421052632	BCL2L1
154	Rhabdomyosarcoma alveolar	C0035412	1	381	0.0	0.0009005847953216374	BCL2L1
155	Gastric ulcer	C0038358	1	116	0.0	0.0009064327485380117	BCL2L1
156	Hepatic cancer metastatic	C0345904	1	613	0.0	0.000912280701754386	BCL2L1
157	Acute megakaryocytic leukemia	C0023462	1	106	0.0	0.0009181286549707603	BCL2L1
158	Well Differentiated Oligodendroglioma	C0751396	1	191	0.0	0.0009239766081871345	BCL2L1
159	Multiple Sclerosis	C0026769	1	1140	0.0	0.0009298245614035087	BCL2L1
160	Neoplasm, Residual	C0242596	1	208	0.0	0.000935672514619883	BCL2L1
161	Squamous cell carcinoma	C0007137	1	1855	0.0	0.0009415204678362573	BCL2L1
162	Colorectal Neoplasms	C0009404	1	1164	0.0	0.0009473684210526315	BCL2L1
163	Multiple Myeloma	C0026764	1	1236	0.0	0.0009532163742690059	BCL2L1
164	Malignant mesothelioma	C0345967	1	266	0.0	0.0009590643274853801	BCL2L1
165	Ovarian epithelial cancer	C0677886	1	2172	0.0	0.0009649122807017544	BCL2L1
166	Lung cancer	C0684249	1	2234	0.0	0.0009707602339181287	BCL2L1
167	Verotoxigenic Escherichia coli gastrointestinal tract infection	C0009450	1	1111	0.0	0.000976608187134503	BCL2L1
168	Animal Mammary Neoplasms	C0024667	1	2352	0.0	0.0009824561403508772	BCL2L1
169	Carcinoma of colon	C0699790	1	1856	0.0	0.0009883040935672516	BCL2L1
170	Chondrosarcoma	C0008479	1	222	0.0	0.0009941520467836257	BCL2L1
171	Stomach Neoplasms	C0038356	1	916	0.0	0.001	BCL2L1
